AET - Aetna Inc.

NYSE - NYSE Delayed Price. Currency in USD
187.22
-2.82 (-1.48%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Previous Close190.04
Open0.00
Bid183.20 x 100
Ask188.00 x 200
Day's Range0.00 - 0.00
52 Week Range
Volume200
Avg. Volume1,970,298
Market Cap61.24B
Beta0.73
PE Ratio (TTM)17.77
EPS (TTM)10.54
Earnings DateAug 2, 2018
Forward Dividend & Yield2.00 (1.08%)
Ex-Dividend Date2018-07-24
1y Target Est203.19
Trade prices are not sourced from all markets
  • ACCESSWIRE57 minutes ago

    Ex-Dividend Alert: Aetna Has an Annualized Pay-Out of $2.00 Per Share; Will Trade Ex-Dividend on July 24, 2018

    Active-Investors has a free review on Aetna Inc. (NYSE: AET) following the Company's announcement that it will begin trading ex-dividend on July 24, 2018. To capture the dividend payout, investors must purchase the stock a day prior to the ex-dividend date that is by latest at the end of the trading session on July 23, 2018. Active-Investors has initiated due-diligence on this dividend stock.

  • Business Wire4 days ago

    Aetna to Announce Second-Quarter 2018 Results

    Aetna today announced that second-quarter 2018 results will be made public on Thursday, August 2, at 6:30 a.m. ET. Given the pending transaction with CVS Health, Aetna will not host a conference call in conjunction with its earnings release.

  • United Health Stock Remains a Safe, If Long Term Insurance Bet
    InvestorPlace4 days ago

    United Health Stock Remains a Safe, If Long Term Insurance Bet

    By all rational measures, United Health (NYSE:UNH) produced a very solid performance for its second quarter fiscal 2018 earnings report. The country’s biggest health-insurance provider exceeded profitability expectations, while meeting the consensus target for revenues. While the “paper stats” were impressive – United Health hit an earnings per share of $3.14, up 3.2% from the $3.04 consensus target – Barron’s Teresa Rivas notes that much of the positive surprise boils down to non-operating factors.

  • Trump's Drug-Price Push Butts Into Two Megadeals
    Bloomberg4 days ago

    Trump's Drug-Price Push Butts Into Two Megadeals

    Donald Trump’s drug-price push is steering right into health megadeals. The Trump administration’s budget office was sent a proposal by the Health and Human Services Department late Wednesday that seems to target pharmacy benefit managers — the middlemen in the pricing process — as part of efforts to change the way drugs are paid for.

  • ACCESSWIRE10 days ago

    Free Pre-Market Technical Recap on CVS Health and Three Additional Health Care Plans Stocks

    Stock Research Monitor: ESRX, AET, and ANTM LONDON, UK / ACCESSWIRE / July 13, 2018 / If you want a free Stock Review on CVS sign up now at www.wallstequities.com/registration . On Thursday, July 12, 2018, ...

  • In attorney general's suit against Sutter, stakes are high for health care industry, Sacramento economy
    American City Business Journals11 days ago

    In attorney general's suit against Sutter, stakes are high for health care industry, Sacramento economy

    Attorney General Xavier Becerra's antitrust suit against the Sacramento region's largest private employer seeks to bring down the cost of health care throughout Northern California.

  • Reuters11 days ago

    Deals of the day-Mergers and acquisitions

    (Adds Intel, Thyssenkrupp, Gawker.com, CVS Health Corp, Borsalino, FPT Corp, KMG International; Updates Sky, Linde, Freeport-McMoRan) July 12 (Reuters) - The following bids, mergers, acquisitions and disposals ...

  • Reuters11 days ago

    U.S. DoJ will not challenge Aetna-CVS deal - report

    (Reuters) - Shares of CVS Health Corp and health insurer Aetna Inc rose more than 2 percent on Thursday after CNBC reported that the U.S. Justice Department will not challenge their planned merger. CNBC ...

  • U.S. DoJ will not challenge Aetna-CVS deal: report
    Reuters11 days ago

    U.S. DoJ will not challenge Aetna-CVS deal: report

    Shares of CVS Health Corp and health insurer Aetna Inc rose more than 2 percent on Thursday after CNBC reported that the U.S. Justice Department will not challenge their planned merger. CNBC said Bloomberg ...

  • CVS, Aetna Shares Jump on Report About Deal's Antitrust Status
    Bloomberg11 days ago

    CVS, Aetna Shares Jump on Report About Deal's Antitrust Status

    Shares of CVS Health Corp. and Aetna Inc. spiked Thursday after a report by Reorg Research that U.S. antitrust enforcers might not move to block the health-care companies’ deal.

  • CVS, Aetna Shares Jump on Report About Deal's Antitrust Status
    Bloomberg11 days ago

    CVS, Aetna Shares Jump on Report About Deal's Antitrust Status

    Shares of CVS Health Corp. and Aetna Inc. spiked Thursday after a report by Reorg Research that U.S. antitrust enforcers might not move to block the health-care companies’ deal.

  • CNBC11 days ago

    CVS, Aetna shares rise on report DoJ won't challenge their merger deal

    Shares of CVS Health and Aetna rose Thursday on a report the Department of Justice won't challenge their merger. Drugstore chain and pharmacy benefits manager CVS announced in December it would acquire health insurer Aetna for $69 billion in a deal that could reshape the health industry. Shares of CVS Health CVS and Aetna AET rose Thursday on a report the Department of Justice won't challenge their merger.

  • Business Wire11 days ago

    Aetna Donates Narcan to Wayne County

    Kathryn Helmuth, M.D., Medical Director of the Wayne County Health Department, today accepted a donation of 192 Narcan (naloxone) kits from Aetna (AET) and the Aetna Foundation to combat the ongoing opioid crisis in Wayne County. Aetna’s donation is the first of its kind to a county in Ohio. The kits, valued at $15,000, will be distributed by the Wayne County Department of Health and the Wayne County Sheriff’s Department to be utilized throughout Wayne County.

  • Financial Times11 days ago

    [$$] CVS, Aetna shares lifted by report that DoJ may clear $69bn deal

    CVS shares were up 2.5 per cent to $69.03, while Aetna shares ticked higher to trade up 2.3 per cent at $191.82. The moves come after a report from trade publication Reorg Research, cited by Bloomberg, that said US antitrust enforcers might not challenge the deal. US Department of Justice staff are expected to voice their support in a recommendation to senior officials, Reorg Research reported, according to Bloomberg.

  • The Zacks Analyst Blog Highlights: Mastercard, Gilead, Goldman Sachs, PepsiCo and Aetna
    Zacks13 days ago

    The Zacks Analyst Blog Highlights: Mastercard, Gilead, Goldman Sachs, PepsiCo and Aetna

    The Zacks Analyst Blog Highlights: Mastercard, Gilead, Goldman Sachs, PepsiCo and Aetna

  • 4 Reasons That Make WellCare Health Plans an Attractive Pick
    Zacks13 days ago

    4 Reasons That Make WellCare Health Plans an Attractive Pick

    WellCare Health Plans (WCG) looks attractive given its promising growth prospects.

  • Benzinga13 days ago

    Benzinga's Daily Biotech Pulse: Acceleron On Fast Lane, OncoCyte's Accurate Diagnosis, Inspire Medical Gets Aetna Coverage

    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on July 9) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) Arrowhead Pharmaceuticals ...

  • Boyle development lands Aetna's 200-job expansion
    American City Business Journals14 days ago

    Boyle development lands Aetna's 200-job expansion

    About one year from now, a health insurance giant expects to open a new office in a sprawling mixed-use development in Franklin. Aetna Inc. (NYSE: AET) has struck a deal with Boyle Investment Co. for a new building at Boyle's Berry Farms development. Berry Farms is so large that it spans three of the four quadrants at exit 61 of Interstate 65, encompassing 600 acres south of Franklin's Cool Springs commercial hub.

  • With $3.4 billion already pledged, digital health investment in 2018 could break records
    American City Business Journals18 days ago

    With $3.4 billion already pledged, digital health investment in 2018 could break records

    Investment in digital health companies continues its strong showing in 2018 with $3.4 billion raised in the first half of the year, according to data from Rock Health. If funding continues on this trajectory, Rock Health predicts that 2018 will surpass 2017's all-time high of $5.6 billion of investment. Rock Health Managing Director Bill Evans pointed to two factors that underscore the industry’s maturation.

  • Allina-Aetna CEO: New joint venture will 'transform' health care and reduce costs
    American City Business Journals21 days ago

    Allina-Aetna CEO: New joint venture will 'transform' health care and reduce costs

    Tom Lindquist will lead a joint venture launched by Allina Health System and Aetna Inc. into the Twin Cities’ increasingly competitive health insurance market.

  • Barrons.com24 days ago

    Picking Through the Wreckage of Amazon's Pharmacy Move

    Amazon.com’s (AMZN) announcement yesterday that it would buy pharmacy startup PillPack has had quite an effect on the stocks of drug distributors and managed care, and the Street today is picking through the wreckage, arguing for a selective treatment of different parts of the industry. Shares of the pharmacy names were the hardest hit, with Rite Aid (RAD), for example, down 13% since Wednesday’s close, Walgreens Boots Alliance (WBA) down 10%, and CVS (CVS) down 7%. Names in the "pharmacy benefit management” and managed care market have been spared the worse, with Express Scripts (ESRX) down 1.6% since Wednesday and Aetna (AET) down 2.3%, and Cigna (CI) down just 1.3%.

  • Report says DoJ will not challenge Aetna-CVS deal
    CNBC Videos11 days ago

    Report says DoJ will not challenge Aetna-CVS deal

    Bloomberg News reported Reorg Research says justice department staff will approve a merger between Aetna and CVS.